Literature DB >> 10866791

Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation.

M Caraglia1, A Budillon, G Vitale, G Lupoli, P Tagliaferri, A Abbruzzese.   

Abstract

In the past years, the attention of scientists has focused mainly on the study of the genetic information and alterations that regulate eukaryotic cell proliferation and that lead to neoplastic transformation. All therapeutic strategies against cancer are, to date, directed at DNA either with cytotoxic drugs or gene therapy. Little or no interest has been aroused by protein synthesis mechanisms. However, an increasing body of data is emerging about the involvement of translational processes and factors in control of cell proliferation, indicating that protein synthesis can be an additional target for anticancer strategies. In this paper we review the novel insights on the biochemical and molecular events leading to protein biosynthesis and we describe their involvement in cell proliferation and tumorigenesis. A possible mechanistic explanation is given by the interactions that occur between protein synthesis machinery and the proliferative signal transduction pathways and that are therefore suitable targets for indirect modulation of protein synthesis. We briefly describe the molecular tools used to block protein synthesis and the attempts made at increasing their efficacy. Finally, we propose a new multimodal strategy against cancer based on the simultaneous intervention on protein synthesis and signal transduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866791     DOI: 10.1046/j.1432-1327.2000.01465.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

Review 1.  Proapoptotic role of novel gene-expression factors.

Authors:  J V Tapia-Vieyra; P Ostrosky-Wegman; J Mas-Oliva
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.405

Review 2.  eIF5A isoforms and cancer: two brothers for two functions?

Authors:  M Caraglia; M H Park; E C Wolff; M Marra; A Abbruzzese
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

Review 3.  Post-transcriptional control of the interferon system.

Authors:  Khalid S A Khabar; Howard A Young
Journal:  Biochimie       Date:  2007-02-24       Impact factor: 4.079

4.  Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types.

Authors:  J Malta-Vacas; C Aires; P Costa; A R Conde; S Ramos; A P Martins; C Monteiro; M Brito
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

5.  Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.

Authors:  Paul M J Clement; Hans E Johansson; Edith C Wolff; Myung H Park
Journal:  FEBS J       Date:  2006-03       Impact factor: 5.542

6.  A tunable dual-promoter integrator for targeting of cancer cells.

Authors:  Lior Nissim; Roy H Bar-Ziv
Journal:  Mol Syst Biol       Date:  2010-12-21       Impact factor: 11.429

Review 7.  Roles of eukaryotic initiation factor 5A2 in human cancer.

Authors:  Feng-wei Wang; Xin-yuan Guan; Dan Xie
Journal:  Int J Biol Sci       Date:  2013-10-12       Impact factor: 6.580

Review 8.  The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections.

Authors:  Wasim Abbas; Amit Kumar; Georges Herbein
Journal:  Front Oncol       Date:  2015-04-07       Impact factor: 6.244

9.  Blood translation elongation factor-1δ is a novel marker for cadmium exposure.

Authors:  Qian Lu; Yi-Xiong Lei; Chao-Cai He; Zi-Ning Lei
Journal:  Int J Mol Sci       Date:  2013-03-04       Impact factor: 5.923

10.  Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1.

Authors:  J Eberle; L F Fecker; J-U Bittner; C E Orfanos; C C Geilen
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.